SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Datek Brokerage $9.95 a trade -- Ignore unavailable to you. Want to Upgrade?

To: Moominoid who wrote (8415)5/4/1998 10:18:00 AM
From: Gorak Shep  Read Replies (1) | Respond to of 16892
 
No, ENMD is NOT an IPO. It closed Friday at 12+, opened today near 85 and is now about 47. All based on a New York Times article re: cancer treatment progress in rats. This is just the now standard market lunacy.



To: Moominoid who wrote (8415)5/4/1998 10:25:00 AM
From: jawd  Read Replies (1) | Respond to of 16892
 
It's quite amazing that Datek's rep posts a message here asking for 3 things that need improving when there's been about 300 messages here in the last 3 weeks telling them exactly what's wrong which they've totally ignored.

As if they don't know already .... jeez!



To: Moominoid who wrote (8415)5/4/1998 10:40:00 AM
From: Jon Tara  Respond to of 16892
 
[Off-topic, ENMD] Too bad I missed this one! The story appeared in the local paper (San Diego Union) but did NOT mention any company associated with the study. I had assumed that it was strictly university research at this point.

This is the craziest one I've ever seen... To say that it taxes my quote service is a severe understatement. :)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News